Trials / Unknown
UnknownNCT05543863
Pharmacokinetics of Oral Antiplatelet Agents After Distal Gastrectomy
Impact of Radial Distal Gastrectomy for Gastric Cancer on the Pharmacokinetics of Oral Antiplatelet Agents
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (estimated)
- Sponsor
- Kyungpook National University Chilgok Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
This study is aimed to investigate the changes in pharmacokinetics and efficacy of antiplatelet agents before and after distal gastrectomy in gastric cancer patients taking oral antiplatelet agents for primary or secondary treatment for cardiovascular disease and to evaluate its impact on the occurrence of postoperative bleeding complications and thromboembolic events.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Platelet function testing | platelet function testing (Platelet function analyzer-100 (PFA-100) collagen epinephrine closure time, VerifyNowⓇ Assays (aspirin, P2Y12)) before surgery and 5 days, 3 months after surgery |
Timeline
- Start date
- 2022-08-20
- Primary completion
- 2023-03-31
- Completion
- 2023-05-31
- First posted
- 2022-09-16
- Last updated
- 2022-09-21
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05543863. Inclusion in this directory is not an endorsement.